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Background: Elevated levels of pro-inﬂammatory mediators heighten the risk of developing or aggra-
vating a spectrum of chronic diseases and are a strong predictor of mortality in elderly cohorts. Omega-3
polyunsaturated fatty acids (n-3PUFA), including eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA), are known to possess anti-inﬂammatory properties. However, the relationship between eryth-
rocyte membrane n-3PUFA and inﬂammation biomarkers has not been well established.
Objective: This study aimed to determine if n-3PUFA status, together with the omega-3 index (O3I,
erythrocyte membrane % EPA plus DHA), is associated with pro-inﬂammatory mediators in older
Australians.
Methods: The study was a cross-sectional analysis of randomly selected older men and women aged 65
years (n ¼ 620) recruited from the Central Coast of NSW, Australia. Fasted blood samples were analysed
for C-reactive protein (CRP), ﬁbrinogen and full blood count using standardised laboratory methods. The
fatty acid composition of erythrocyte membranes was analysed via gas chromatography to determine n-
3PUFA levels. The relationships between n-3PUFA and inﬂammatory mediators were evaluated in
multivariate regression models after adjusting for known inﬂammatory confounders.
Results: After excluding participants who had an inﬂammatory disease, CRP levels >10 mg/L, or who
were taking anti-inﬂammatory medications or n-3PUFA supplements, 126 participants (age 77.6 ± 7.3
years; females, 46%) were included in the analysis. After multivariate adjustments, O3I was inversely
associated with CRP (b ¼ 0.209, p < 0.05) and monocyte cell counts (b ¼ 0.205, p < 0.05), and total n-
3PUFA was inversely related to WBC (b ¼ 0.238, p < 0.05), neutrophils (b ¼ 0.212, p < 0.05) and
monocytes (b ¼ 0.246, p < 0.05). However no association between ﬁbrinogen and O3I or total n-3PUFA
was detected.
Conclusions: This study demonstrated a negative association between O3I and biomarkers of inﬂam-
mation in an older population. The ﬁndings support a potential role for n-3PUFA supplementation in the
management of inﬂammatory diseases.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pro-inﬂammatory mediators (including cytokines and eicosa-
noids) have been shown to be elevated in elderly people by asmuch
as two-to four-fold, when compared to a younger population [1].ing, University of Newcastle,
M.L. Garg).
Inc. This is an open access article uSustained low grade inﬂammation indicated by increased circu-
lating levels of C-reactive protein (CRP) is a strong predictor of
mortality in elderly cohorts irrespective of concurrent morbidities
or other known risk factors such as smoking or high blood pressure
[1]. The inﬂammatory process is designed to help ﬁght infection,
remove harmful substances and repair damaged tissue and organ
systems [2]. Although this process is generally protective, failure to
resolve the inﬂammatory response can result in chronic inﬂam-
mation, which may lead to the development and progression of ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Overview of participant recruitment.
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Alzheimer's disease, depression, rheumatoid arthritis, cancer, sar-
copenia and reduced physical functioning [1,3e5].
Elevated levels of acute phase proteins, C-reactive protein (CRP)
and ﬁbrinogen are reliable markers of sustained lowgrade systemic
inﬂammation [6e8]. CRP and ﬁbrinogen are released by hepato-
cytes in response to elevated cytokine levels during the acute in-
ﬂammatory response. Fibrinogen is also a principal protein
involved in blood clotting [7].
Omega-3 polyunsaturated fatty acids (n-3PUFA) of marine
origin have attracted attention due to their anti-inﬂammatory ef-
fects [9]. The proposed mechanisms by which n-3PUFA mediates
these effects include preferential incorporation of n-3PUFA into
phospholipids resulting in the production of 3-series eicosanoids
with lower biological activity, production of inﬂammation
resolving lipid mediators (resolvins and protectins) and altered
cytokine gene expression [2].
Most epidemiological and experimental studies have shown an
association between higher plasma n-3PUFA levels and reductions
in circulating plasma inﬂammatory mediators; interleukin-6 (IL-6),
tumour necrosis factor-alpha (TNF-a) and CRP [10e13]. However,
randomised controlled trials involving n-3PUFA supplementation
have produced inconsistent results. Rangel-Heurta et al. were un-
able to draw a clear conclusion on the association between plasma
n-3PUFA levels and reductions in inﬂammatory mediators, due to
heterogeneity in study methodologies that include variations in
study population, supplement dosage, study length, and sample
size [14]. The strongest associations between plasma n-3PUFA
levels and inﬂammatory mediators have been found in older pop-
ulations, and in populations with elevated inﬂammatory bio-
markers [15,16]. More recently a meta-analysis of randomised
controlled trials by Li et al. reported a reduction in inﬂammatory
mediators upon n-3PUFA supplementation in healthy and diseased
populations [17].
The omega-3 index (O3I) is deﬁned as the sum of EPA and DHA
expressed as a percentage of total erythrocyte fatty acids [18]. O3I
has been shown to correlate with n-3PUFA levels in body tissues
[18] and is considered a reliable biomarker of long term n-3PUFA
intake. The determination of O3I provides an opportunity to
examine potential associations between n-3PUFA dietary intake
and reductions in inﬂammatory biomarkers such as CRP and
ﬁbrinogen. To date, the association of O3I levels and inﬂammatory
biomarkers has only been exploredwithin unhealthy ormoderately
hypertriglyceridemic populations and has produced inconsistent
results [12,19,20]. The aim of this project was to determine if n-
3PUFA status, and in particular O3I, is associatedwith inﬂammatory
mediators in older Australians. Our recent studies have demon-
strated that the association between n-3PUFA status and chronic
disease risk factors is sex-dependent [21,22], therefore, we exam-
ined the relationship between n-3PUFA and inﬂammation media-
tors separately in older men and women.
2. Materials and methods
2.1. Study population and design
This study is a cross-sectional analysis of data collected as part of
the Retirement Health and Lifestyle Study (RHLS); a study of the
health and lifestyle of older Australians (65 years and older)
residing in retirement villages or within the community in the
Central Coast region of NSW, Australia. Participants were eligible
for the RHLS if they: were65 years of age; their primary residence
was located within theWyong or Gosford Local Government Areas;
and they had been living at their current address for 12 months.
Participants were not eligible if: theywere not living independentlyor were residing in a communal setting other than a retirement
village; another member of their household was taking part in the
study; they had language and/or other communicative difﬁculties
that limited participation; or theywere cognitively impaired and/or
were unable to provide informed consent. Those who were eligible
and chose to participate in the study (n ¼ 831) took part in an
interviewer-administered questionnaire (IAQ) adapted from vali-
dated lifestyle surveys [21e24]. A subset of eligible participants
completed a clinical assessment (n ¼ 670) and provided a blood
sample (n¼ 649). Participants were included in the present study if
they had erythrocyte samples available for fatty acid analyses
(n ¼ 620) and valid anthropometric and inﬂammatory marker
measurements. Participants with CRP levels10mg/L (indicative of
acute inﬂammation), and/or who reported inﬂammatory disease
(e.g. arthritis), and/or that they were taking anti-inﬂammatory
medication or n-3PUFA supplements [25] were excluded from the
analyses. All subjects provided written informed consent, and the
study was approved by the University of Newcastle Human
Research Ethics Committee (H-2008-0431) and the Northern Syd-
ney Central Coast Health Human Research Ethics Committee
(Reference No. 1001-031M). The participant recruitment process is
summarised in Fig. 1.
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Blood samples were collected from subjects in a fasting state
(>10 h) by a trained phlebotomist. Participants were asked to
abstain from smoking on the morning of collection and to rest for
5 min prior to sample collection. CRP, ﬁbrinogen, and white blood
cell counts (WBC) including WBC differentials were analysed using
standardised methodology by an accredited pathology service
(Hunter New England Area Pathology Service).
For erythrocyte membrane fatty acid composition determina-
tion, blood samples were ﬁrst centrifuged at 3000g for 10 min to
separate the plasma and erythrocyte fractions. Fatty acid proﬁles
were analysed using the method of Lepage and Roy via direct trans-
esteriﬁcation of the washed red blood cell (RBC) fraction followed
by gas chromatography [26]. Methanol:toluene (2 mL, 4:1 v/v,
containing C19:0 as internal standard) was added to the erythro-
cyte samples. Acetyl chloride (200 mL) was added while vortexing
and the samples were then heated for 1 h at 100 C. After the
samples were cooled inwater for 5min, K2CO3 6% (5mL) was added
and the samples were centrifuged (3000g, 5 min, 4 C). The upper
toluene phase was collected and stored at 20 C until GC analysis.
Methylated fatty acid samples were analysed using a Hewlett
Packard 6890 Series GC equipped with a ﬁxed carbon-silica column
30 m  0.25 mm (DB-225) (J and W Scientiﬁc), ﬂame ionization
detector, autosampler and autodetector. Injector and detector ports
were set at 250 C. The oven temperature was programmed at:
170 C for two minutes then increased 10 C per minute to 190 C
where it remained stationary for one minute, then increased 3 C
per minute to 220 C, and held for a total run time of 30 min per
sample. A split ratio of 10:1 and an injection volume of 3 mL were
used. Sample peaks were identiﬁed by comparison of retention
times to known fatty acid standards. Fatty acid proﬁle data were
stored and processed using Hewlett Packard Chemstations Version
A. 04.02 software. The O3I was calculated by summing the peak
area of erythrocytemembrane EPA and DHA andwas expressed as a
percentage of the total peak area for all erythrocytemembrane fatty
acids measured and total n-3PUFA was calculated by summing a-
linolenic acid (ALA), EPA, docosapentaenoic acid (DPA) and DHA.
2.3. Demographic, physical activity, medical history and dietary
intake
Demographic data (sex, age, marital status, income, employ-
ment, education and country of birth), and information about
smoking and participation in physical activity, was collected via an
IAQ. Information about diagnosed conditions, medical history and
health status was collected via a self-administered medical history
questionnaire. Food intake was assessed via a self-administered
food frequency questionnaire (FFQ) adapted from the validated
interviewer administered CSIRO FFQ [27]. Dietary data was ana-
lysed using FoodWorks Professional Edition 2009, Version 6.0.2562
(Xyris software, Brisbane, QLD, Australia).
2.4. Anthropometrics
Anthropometric measures, including height, weight, waist and
hip circumference, were taken by trained research ofﬁcers ac-
cording to World Health Organisation guidelines [28]. Body weight
in light clothing and without shoes was measured using a digital
scale (Tanita HD316, Tanita Corporation, Tokyo, Japan; or Wedder-
burn UWPM150; Wedderburn Scales, Australia) to the nearest
100 g, with subject's weight evenly distributed on the scales. Height
was measured using a portable stadiometer (Design No.1013522,
Surgical &Medical Products, Australia) to the nearest 0.1 cm. Waist
circumferencewasmeasured at themid-point of thewaist betweenthe lower coastal arch and the iliac crest using a soft measuring
tape, to the nearest 0.1 cm and upon normal expiration. Hip
circumference was measured at the greatest posterior protuber-
ance of the gluteal to the nearest 0.1 cm. Measurement was taken
upon normal expiration. All anthropometric measurements were
taken twice. If the measurements disagreed by more than set
tolerance limits a third measure was taken. Each measure was
presented as the mean of the two observations or the mean of the
two closest measurements if a third was taken. The mean height
and weight were used to calculate body mass index (kg/m2).
2.5. Sitting blood pressure
Seated blood pressure was measured by trained staff using a
calibrated Omron 1A2 digital automatic blood pressure monitor
(Omron, Australia) as per the National Heart Foundation Guidelines
[29]. Participants were asked to avoid strenuous exercise for 24 h
prior to measurement, fast overnight, and abstain from smoking on
the morning of measurement. Serial readings were taken (mini-
mum of three), and the average of the last two readings within
10 mmHg SBP and 6 mmHg DBP were recorded.
2.6. Statistical analysis
Data was analysed using Statistical Package for the Social Sci-
ences (SPSS; Release 17.0, Chicago, IL: SPSS Inc). Descriptive sta-
tistics were undertaken for total group, men and women.
Continuous data was reported as mean ± standard deviation (SD).
Categorical data were reported as frequencies and/or percentages.
Group differences between male and female subgroups were
assessed using independent samples t-tests (two-tailed) and chi-
square analyses. Pearson product-moment correlation analyses
were used to evaluate the association between erythrocyte mem-
brane n-3PUFA levels and plasma inﬂammatory mediators (CRP,
ﬁbrinogen,WBCs andWBC differentials). Differences in the number
of participants with pro-inﬂammatory mediator levels above and
within reference ranges in O3I quartiles was evaluated using a
linear-by-linear association chi-square test [30,31].
Two-block hierarchical multiple regression analyses were used
to examine the relationship between O3I and total n-3PUFA and
speciﬁc inﬂammatory mediators [32,33]. Anthropometric, de-
mographic and other potentially confounding variables (age, sex,
BMI, systolic blood pressure, smoking status, sedentary lifestyle,
fasting blood glucose, total cholesterol and triglycerides) were
entered into the regression analyses at block 1. Either O3I or total n-
3PUFA was entered at the second block of the analysis. The multi-
variate relationships between select inﬂammatory mediators and
O3I or total n-3PUFAwere analysed separately to avoid co-linearity.
Pairwise exclusion for missing data was employed in all analyses.
Statistical signiﬁcance was set at p < 0.05.
3. Results
After excluding those participants who reported a pre-existing
inﬂammatory disease and/or had CRP levels >10 mg/L (n ¼ 236),
together with those who were taking anti-inﬂammatory medica-
tions (n ¼ 221) or n-3PUFA supplements (n ¼ 37), 126 participants
(age 77.6 ± 7.3 years; females 46%) remained in the analysis
(Table 1). As expected there was a signiﬁcant difference between
males and females for height (p < 0.001), body weight (p < 0.001),
and waist circumference (p < 0.001), being higher in men. Waist-
to-hip ratio (WHR) was also signiﬁcantly higher in men
(p < 0.001). The mean waist circumference for men and women
were both above the National Heart Foundation deﬁned cut-off
points (men, <94 cm; women, <80 cm) for increased risk of heart
Table 1
Characteristics of the study participants.a
All Men Women p
(n ¼ 126) (n ¼ 68) (n ¼ 58)
Age (years) 77.6 ± 7.3 78.3 ± 7.2 76.9 ± 7.3 NS
Current smoker (n, %) 3 (2.4%) 2 (2.9%) 1 (1.7%) NS
Physical inactivity (n, %) 8 (6.3%) 4 (5.9%) 4 (6.9%) NS
Height (m) 1.65 ± 0.09 1.70 ± 0.07 1.59 ± 0.07 <0.001
Weight (kg) 74.4 ± 14.6 79.8 ± 14.1 68.3 ± 12.6 <0.001
BMI (kg/m2) 27.0 ± 4.0 27.2 ± 3.9 26.9 ± 4.2 NS
Waist (cm) 96.8 ± 12.1 101.8 ± 10.9 90.9 ± 10.9 <0.001
Hip (cm) 106.8 ± 8.6 106.3 ± 6.9 107.3 ± 10.3 NS
Waist: Hip ratio 0.91 ± 0.08 0.95 ± 0.06 0.85 ± 0.05 <0.001
SBP (mmHg) 147.3 ± 21.2 150.3 ± 19.4 143.9 ± 22.8 NS
DBP (mmHg) 75.1 ± 10.1 76.4 ± 9.7 73.5 ± 10.4 NS
Total protein (g/L) 76.3 ± 4.3 76.7 ± 4.1 75.9 ± 4.6 NS
Glucose (mmol/L) 5.5 ± 1.0 5.6 ± 1.0 5.4 ± 0.9 NS
Total cholesterol (mmol/L) 4.7 ± 1.0 4.5 ± 0.9 5.0 ± 1.0 <0.01
Triglycerides (mmol/L) 1.2 ± 0.5 1.2 ± 0.5 1.3 ± 0.6 NS
LDL (mmol/L) 2.6 ± 0.9 2.5 ± 0.8 2.8 ± 0.9 <0.05
HDL (mmol/L) 1.5 ± 0.5 1.4 ± 0.4 1.7 ± 0.5 <0.01
BMI¼ body mass index, DBP ¼ diastolic blood pressure, SBP ¼ systolic blood pressure, HDL ¼ high-density lipoproteins, LDL ¼ low-density lipoproteins, NS ¼ not statistically
signiﬁcant at p < 0.05.
a Data are presented as mean and standard deviation or number and (%). Continuous variables were compared across gender subgroups using two-tailed independent
samples student t-tests. Categorical variables were compared across gender subgroups using Pearson's chi-square tests.
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(p < 0.05) and HDL-cholesterol (p < 0.01) was higher in women,
while mean systolic and diastolic blood pressure was similar be-
tween males and females. The prevalence of smoking and physical
inactivity was also similar across the two genders (Table 1). There
were no signiﬁcant differences in the dietary intake of macronu-
trients between male and female participants (Table 2). Compared
to males, female participants had higher erythrocyte membrane
DHA (p < 0.05), O3I (p < 0.05), and total n-3PUFA (p < 0.05)
(Table 3).
Females had signiﬁcantly lower monocyte (p < 0.001) and
eosinophil (p < 0.05) cell counts than males, while total WBC,
neutrophil, lymphocyte and eosinophil cell counts, and plasma
ﬁbrinogen and CRP levels were not signiﬁcantly different between
the gender sub-groups (Table 4).
The results of bivariate correlation analyses of the relationships
between erythrocyte membrane n-3PUFA and the various inﬂam-
matory markers are presented in Table 5. With the exception of the
inverse relationship detected between ﬁbrinogen and DPA in male
participants, ﬁbrinogen, lymphocytes and basophils were not
correlated with any of the n-3PUFA reviewed. In contrast, CRP,
WBC, neutrophils, monocytes and eosinophils displayed negative
correlations with a number of n-3PUFA. CRP was inversely corre-
lated to DHA, O3I and total n-3PUFA. These relationships were not
gender speciﬁc, with similar but non-signiﬁcant trends in associ-
ation evident in both gender subgroups. WBC and monocytes wereTable 2
Nutrient intake of the study participants.a
All
(n ¼ 126)
Total energy (kJ/d) 7648±2862
Total lipid (g/d) 66.8±29.5
MUFA (g/d) 25.6±11.8
PUFA (g/d) 10.9±7.4
SFA (g/d) 23.7±11.8
Carbohydrate (g/d) 193.6±80.4
Protein (g/d) 84.8±34.3
MUFA ¼ monounsaturated fatty acids, PUFA ¼ polyunsaturated fatty acids, SFA ¼ satura
a Data are presented as mean and standard deviation. Gender subgroups were companegatively correlated with EPA, DPA, DHA, and consequently O3I
and total n-3PUFA in the analysis of the overall group. Neutrophils
were also negatively correlated with all n-3PUFA variables with the
exception of DHA. Gender speciﬁcity was evident, with the re-
lationships between WBC and n-3PUFA and neutrophils and n-
3PUFA generally displaying speciﬁcity to males, and the relation-
ship between monocytes and DPA displaying speciﬁcity to females.
Eosinophils were also inversely correlated to n-3PUFA in women,
but not men, with signiﬁcant correlations detected between eo-
sinophils and EPA, DHA, O3I and total n-3PUFA.
Hierarchical regression analyses were conducted to assess the
association between key inﬂammatory markers (CRP, WBC, neu-
trophils, monocytes, eosinophils) and n-3PUFA variables (O3I, total
n-3PUFA) after adjusting for potentially confounding variables (age,
gender, BMI, systolic blood pressure, sedentary lifestyle, fasting
glucose, total cholesterol and triglycerides). The multivariate re-
lationships between each inﬂammatory marker and O3I, or total n-
3PUFA, were assessed separately and the results are summarised in
Table 6.
O3I, and total n-3PUFA levels, were signiﬁcantly associated with
monocyte cell counts in all participants, after correcting for the
potentially confounding inﬂuences of age, gender, BMI, systolic
blood pressure, sedentary lifestyle, fasting glucose, total cholesterol
and triglycerides (O3I: R ¼ 0.433, p < 0.05; total n-3PUFA:
R ¼ 0.449, p < 0.01). In both models, the addition of the n-3PUFA
variable at the second block of the analyses resulted in signiﬁcantMen Women p
(n ¼ 68) (n ¼ 58)
7984±2930 7254±2755 NS
67.4±29.4 66.1±29.8 NS
25.7±12.1 25.4±11.6 NS
11.1±7.1 10.7±7.8 NS
23.9±11.9 23.5±11.8 NS
204.2±83.8 181.2±75.0 NS
87.1±30.9 82.1±37.9 NS
ted fatty acids, NS ¼ not statistically signiﬁcant at p < 0.05.
red using two-tailed independent samples student t-tests.
Table 3
Erythrocyte fatty acids (%) of study participants.a
All Men Women p
(n ¼ 126) (n ¼ 68) (n ¼ 58)
SFA
16:0 22.77±1.44 22.81±1.66 22.72±1.16 NS
18:0 18.48±1.44 18.46±1.64 18.51±1.17 NS
20:0 0.64±0.23 0.62±0.24 0.66±0.21 NS
Total SFA 41.89±2.44 41.88±2.80 41.89±1.96 NS
MUFA
16:1n-7 0.55±0.28 0.54±0.32 0.56±0.24 NS
18:1n-7 1.75±0.41 1.73±0.44 1.76±0.38 NS
Total MUFA 2.30±0.60 2.28±0.67 2.32±0.52 NS
n-6PUFA
18:2n-6 9.11±1.62 9.15±1.79 9.06±1.40 NS
18:3n-6 0.22±0.30 0.23±0.37 0.22±0.20 NS
20:2n-6 0.34±0.32 0.37±0.42 0.30±0.11 NS
20:3n-6 1.46±1.11 1.45±1.12 1.47±1.11 NS
20:4n-6 17.04±2.33 17.14±2.30 16.92±2.38 NS
Total n-6PUFA 28.16±2.44 28.34±2.62 27.96±2.23 NS
n-3PUFA
18:3n-3 (ALA) 0.28±0.15 0.28±0.16 0.28±0.15 NS
20:5n-3 (EPA) 1.38±0.65 1.28±0.62 1.49±0.67 NS
22:5n-3 (DPA) 3.46±0.63 3.49±0.65 3.42±0.62 NS
22:6n-3 (DHA) 6.28±1.44 5.98±1.40 6.64±1.41 <0.05
Total n-3PUFA 11.40±2.14 11.03±2.11 11.83±2.11 <0.05
Omega-3 Index 7.66±1.92 7.27±1.83 8.13±1.94 <0.05
ALA ¼ alpha-linolenic acid, DHA ¼ docosahexaenoic acid, DPA ¼ docosapentaenoic
acid, EPA ¼ eicosapentaenoic acid, MUFA ¼ monounsaturated fatty acids, n-
3PUFA ¼ omega-3 polyunsaturated fatty acids, Omega-3 index ¼ Erythrocyte
EPA þ DHA % total fatty acids, n-6PUFA ¼ omega-6 polyunsaturated fatty acids,
PUFA ¼ polyunsaturated fatty acids, SFA ¼ saturated fatty acids, NS ¼ not statisti-
cally signiﬁcant at p < 0.05.
a Data are presented as mean and standard deviation. Gender subgroups were
compared using two-tailed independent samples student t-tests.
Table 4
Biomarkers of inﬂammation in study participants.a
All Men Women p
(n ¼ 126) (n ¼ 68) (n ¼ 58)
Markers of Inﬂammation
Fibrinogen (g/L) 3.5±0.6 3.4±0.5 3.6±0.7 NS
CRP (mg/L) 2.4±2.0 2.3±1.7 2.6±2.3 NS
WBC &WBC differentials
WBC (109/L) 6.29±1.64 6.55±1.64 6.00±1.61 NS
Neutrophils (109/L) 3.81±1.28 3.98±1.20 3.61±1.34 NS
Lymphocyte (109/L) 1.71±0.54 1.70±0.53 1.73±0.55 NS
Monocytes (109/L) 0.54±0.21 0.61±0.23 0.46±0.15 <0.001
Eosinophils (109/L) 0.20±0.15 0.23±0.18 0.16±0.09 <0.05
Basophils (109/L) 0.02±0.04 0.02±0.04 0.02±0.04 NS
CRP¼ C-reactive protein,WBC¼white blood cell, NS¼ not statistically signiﬁcant at
p < 0.05.
a Data are presented as mean and standard deviation. Gender subgroups were
compared using two-tailed independent samples student t-tests.
Table 5
Correlations between erythrocyte fatty acids and biomarkers of inﬂammation.a
Biomarker 20:5n-3
EPA
22:5n-3
DPA
22:6n-3
DHA
Omega-3
Index
Total
n-3PUFA
Fibrinogen
All 0.139 0.138 0.050 0.084 0.112
Men 0.150 0.310* 0.057 0.095 0.178
Women 0.175 0.010 0.100 0.133 0.110
CRP
All 0.160 0.062 0.182* 0.190* 0.193*
Men 0.187 0.170 0.148 0.177 0.211
Women 0.172 0.042 0.258 0.246 0.218
WBC
All 0.213* 0.255** 0.177* 0.204* 0.257**
Men 0.278* 0.306* 0.153 0.212 0.286*
Women 0.095 0.221 0.133 0.130 0.169
Neutrophils
All 0.227* 0.227* 0.172 0.206* 0.247**
Men 0.272* 0.351** 0.100 0.169 0.261*
Women 0.146 0.114 0.190 0.188 0.188
Lymphocytes
All 0.008 0.148 0.007 0.008 0.044
Men 0.157 0.056 0.156 0.173 0.175
Women 0.174 0.256 0.180 0.191 0.093
Monocytes
All 0.227* 0.179* 0.243** 0.258** 0.283**
Men 0.179 0.151 0.166 0.188 0.213
Women 0.208 0.330* 0.214 0.227 0.293*
Eosinophils
All 0.124 0.015 0.178* 0.175 0.162
Men 0.014 0.015 0.047 0.041 0.048
Women 0.271* 0.060 0.354** 0.351** 0.323*
Basophils
All 0.075 0.044 0.029 0.047 0.040
Men 0.170 0.022 0.032 0.019 0.032
Women 0.130 0.135 0.086 0.107 0.114
ALA ¼ alpha-linolenic acid, CRP¼ C-reactive protein, DHA ¼ docosahexaenoic acid,
DPA ¼ docosapentaenoic acid, EPA ¼ eicosapentaenoic acid,
MUFA ¼ monounsaturated fatty acids, n-3PUFA ¼ omega-3 polyunsaturated fatty
acids, Omega-3 index ¼ Erythrocyte EPA þ DHA % total fatty acids, n-
6PUFA ¼ omega-6 polyunsaturated fatty acids, PUFA ¼ polyunsaturated fatty acids,
SFA ¼ saturated fatty acids, WBC ¼ white blood cell.
a Pearson bivariate two-tailed correlation analyses were used to test associations.
Pearson's correlation coefﬁcient (r) presented.*<0.05** < 0.01.
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DR2¼ 4.9%, p < 0.05). O3I and total n-3PUFAwere also independent
negative predictors of monocyte counts in their respective models
(O3I: b ¼ 0.205, p < 0.05; total n-3PUFA: b ¼ 0.246, p < 0.05); as
was gender (O3I: b ¼ 0.300, p < 0.01; total n-3PUFA: b ¼ 0.309,
p < 0.01), with female sex being associated with lower monocyte
counts.
Hierarchical regression analyses of WBC counts against total n-
3PUFA also resulted in a signiﬁcant predictive model and multi-
variate R value, after adjustment for potentially confounding vari-
ables (R ¼ 0.397, p < 0.05). In this analysis, the addition of total n-
3PUFA signiﬁcantly increased the model's predictive power (DR2:
4.6%, p < 0.05) and the negative correlation between total n-3PUFA
and WBC counts was the only relationship that contributedindependently and signiﬁcantly to the multivariate association
observed. A similar but non-signiﬁcant trend in association was
evident for the adjusted analyses of the relationship between WBC
and O3I.
Separate hierarchical regression analyses of O3I and total n-
3PUFA against CRP, neutrophils and eosinophils, adjusted for age,
gender, BMI, systolic blood pressure, sedentary lifestyle, fasting
glucose, total cholesterol and triglycerides, resulted in non-
signiﬁcant models with multivariate correlation coefﬁcients be-
tween 0.311 and 0.349. Despite the lack of model signiﬁcance, the
addition of O3I or total n-3PUFA at the second block of the analyses
contributed signiﬁcantly to the prediction of CRP and neutrophil
cell counts, respectively (DR2 for both models ¼ 3.6%, p < 0.05). O3I
and total n-3PUFA were also the only independent variables to
exert a signiﬁcant independent inﬂuence on CRP levels (b¼0.215,
p ¼ 0.04) and neutrophil cell counts (b ¼ 0.215, p ¼ 0.04), with
higher levels of n-3PUFA associated with lower levels of the in-
ﬂammatory markers.
The percentage of participants with CRP levels within the
reference range for each O3I quartile is presented in Fig. 2. The
proportion of participants with low to average CRP levels (3.0 mg/
L) increased across increasing O3I quartiles (61.3%, 74.2%, 68.8%,
84.4%, p-trend ¼ 0.04), with signiﬁcant differences in the propor-
tion of participants with CRP levels 3 mg/L found between the
ﬁrst (61.3%) and fourth quartiles (84.4%; c2 ¼ 4.26, p ¼ 0.04).
Table 6
Hierarchical regression analysis of the relationship between inﬂammatory markers and (a) O3I and (b) total n-3PUFA.a
CRP WBC Neutrophils Monocytes Eosinophils
(a) & (b) Model 1 R ¼ 0.257,
R2 ¼ 0.066, p ¼ ns
R ¼ 0.334,
R2 ¼ 0.112, p ¼ ns
R ¼ 0.292,
R2 ¼ 0.085, p ¼ ns
R ¼ 0.390,
R2 ¼ 0.152, p < 0.05
R ¼ 0.281,
R2 ¼ 0.079, p ¼ ns
Variables b p b p b p b p b p
Age (yrs) 0.075 ns 0.059 ns 0.021 ns 0.008 ns 0.060 ns
Gender 0.125 ns 0.142 ns 0.095 ns 0.336 0.001 0.218 0.030
BMI 0.048 ns 0.015 ns 0.040 ns 0.042 ns 0.036 ns
SBP 0.067 ns 0.114 ns 0.114 ns 0.042 ns 0.026 ns
Smoking 0.025 ns 0.109 ns 0.097 ns 0.028 ns 0.135 ns
Sedentary lifestyle 0.108 ns 0.064 ns 0.066 ns 0.130 ns 0.051 ns
Glucose 0.039 ns 0.043 ns 0.106 ns 0.040 ns 0.000 ns
Total cholesterol 0.157 ns 0.044 ns 0.101 ns 0.001 ns 0.062 ns
Triglycerides 0.219 ns 0.189 ns 0.139 ns 0.105 ns 0.058 ns
(a) O3I: Model 2 R ¼ 0.320,
R2 ¼ 0.102, p ¼ ns
R ¼ 0.373,
R2 ¼ 0.139, p ¼ ns
R ¼ 0.330,
R2 ¼ 0.109, p ¼ ns
R ¼ 0.433,
R2 ¼ 0.187, p < 0.05
R ¼ 0.324,
R2 ¼ 0.105, p ¼ ns
DR2 ¼ 0.036,
p < 0.05
DR2 ¼ 0.028, p ¼ ns DR2 ¼ 0.023, p ¼ ns DR2 ¼ 0.035,
p < 0.05
DR2 ¼ 0.026, p ¼ ns
Variables b p b p b p b p b p
Age (yrs) 0.085 ns 0.051 ns 0.013 ns 0.002 ns 0.069 ns
Gender 0.162 ns 0.110 ns 0.066 ns 0.300 0.002 0.187 ns
BMI 0.003 ns 0.054 ns 0.004 ns 0.086 ns 0.074 ns
SBP 0.084 ns 0.128 ns 0.128 ns 0.059 ns 0.040 ns
Smoking 0.003 ns 0.128 ns 0.115 ns 0.050 ns 0.154 ns
Sedentary lifestyle 0.094 ns 0.052 ns 0.055 ns 0.117 ns 0.039 ns
Glucose 0.071 ns 0.016 ns 0.081 ns 0.009 ns 0.027 ns
Total cholesterol 0.104 ns 0.002 ns 0.058 ns 0.053 ns 0.106 ns
Triglycerides 0.176 ns 0.152 ns 0.105 ns 0.064 ns 0.022 ns
O3I 0.209 0.045 0.183 ns 0.168 ns 0.205 0.035 0.177 ns
(b) Total n-3PUFA: Model 2 R ¼ 0.311,
R2 ¼ 0.097, p ¼ ns
R ¼ 0.397,
R2 ¼ 0.158, p < 0.05
R ¼ 0.349,
R2 ¼ 0.122, p ¼ ns
R ¼ 0.449,
R2 ¼ 0.201, p < 0.01
R ¼ 0.321,
R2 ¼ 0.103, p ¼ ns
DR2 ¼ 0.031, p ¼ ns DR2 ¼ 0.046,
p < 0.05
DR2 ¼ 0.036,
p < 0.05
DR2 ¼ 0.049,
p < 0.05
DR2 ¼ 0.024, p ¼ ns
Variables b p b p b p b p b p
Age (yrs) 0.092 ns 0.039 ns 0.003 ns 0.013 ns 0.075 ns
Gender 0.147 ns 0.116 ns 0.072 ns 0.309 0.001 0.199 0.047
BMI 0.012 ns 0.058 ns 0.002 ns 0.086 ns 0.067 ns
SBP 0.077 ns 0.125 ns 0.125 ns 0.054 ns 0.035 ns
Smoking 0.005 ns 0.134 ns 0.120 ns 0.054 ns 0.154 ns
Sedentary lifestyle 0.096 ns 0.049 ns 0.053 ns 0.115 ns 0.040 ns
Glucose 0.058 ns 0.021 ns 0.087 ns 0.017 ns 0.016 ns
Total cholesterol 0.086 ns 0.042 ns 0.024 ns 0.091 ns 0.125 ns
Triglycerides 0.170 ns 0.130 ns 0.086 ns 0.044 ns 0.015 ns
Total n-3PUFA 0.195 ns 0.238 0.018 0.212 0.038 0.246 0.012 0.173 ns
a Two block hierarchical multiple regression analysis was conducted. O3I: Omega-3 index¼ erythrocyte %EPAþ%DPA of total erythrocyte fatty acids [50]. Total n-3PUFA¼ %
EPAþ%DPAþ%DHA.
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levels (0.8  109/L) increased across increasing quartiles of O3I
(80.6%, 93.5%, 93.8%, 100.0%, p-trend ¼ 0.007; Fig. 2), with signiﬁ-
cant differences in the proportion of participants with monocyte
levels  0.8  109/L found between the ﬁrst (80.6%) and fourth
quartiles (100%; c2 ¼ 6.85, p ¼ 0.009). The proportion of partici-
pants with normal ﬁbrinogen, WBC, neutrophil, lymphocyte, and
eosinophil levels did not differ between O3I quartiles (data not
shown). Basophils were not analysed because the basophil data for
all participants were within the reference range.4. Discussion
The aim of this cross sectional study was to determine whether
erythrocyte n-3PUFA status, and in particular O3I, is a predictor of
inﬂammation in older Australians. This study revealed a signiﬁcant
inverse association between O3I and the inﬂammatory mediators,
CRP, WBC, neutrophils and monocytes. To date literature on the
association between erythrocyte n-3PUFA levels, in particular O3I,
and inﬂammation has been limited, therefore the results of this
current study represent novel ﬁndings. Previous observationalstudies have generated conﬂicting results regarding the effect of
dietary n-3PUFA intake on inﬂammatory biomarkers [11,13,35e40].
Prior studies have determined n-3PUFA levels using self-reported
dietary intake, which is limited by recall bias and does not ac-
count for absorption or metabolism, or plasma n-3PUFA levels,
which are a short term rather than long-term indicator of dietary
intake [18,41].
An inverse association between O3I with CRP and IL-6 has
previously been reported in a study of 992 predominantly male
patients with coronary artery disease, aged 64 years and over [12].
Similarly, in a study of 357 healthy Yup'ik eskimos, there was an
inverse association between erythrocyte DHA and EPA with CRP
levels, however O3I was not reported in this study and several
important confounders, such as physical activity and blood pres-
sure, were not accounted for in the multivariate analysis [42].
Conversely, a study of healthy Italian participants aged 20e98
years, did not ﬁnd an association between erythrocyte n-3PUFA
levels and CRP [10]. However, the levels of CRP and erythrocyte EPA
and DHA reported were low, which may have attenuated any po-
tential relationship.
The O3I values in the current study were higher than those
Fig. 2. The percentage of older adults (aged 65yrs) with CRP levels or monocyte
counts within reference ranges for each O3I quartile. A. The percentage of participants
within each O3I quartile with CRP levels 3.0 mg/L or >3.1 mg/L [30]. B. The per-
centage of participants within each O3I quartile with monocyte count 0.8  109/L or
>0.8  109/L [31].
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study population may have contributed to the higher overall O3I
mean. A cross sectional study of 160,000 American participants
found that O3I can increase by asmuch as 7% per decade up until 70
years [43]. Variations in the methodologies used to analyse eryth-
rocyte membrane fatty acids may also result in different mean
values between studies [44]. Regardless, the relationships and
trends found would be comparable.
The results of this study may have also been inﬂuenced by the
BMI of participants (27.0 ± 4.0 kg/m2). BMI was adjusted for within
the multivariate regression analyses, however, the percentage of
obese participants within this study population was relatively low.
Le et al. found in a systematic review andmeta-analysis of RCTs that
n-3PUFA reduce plasma CRP in subjects with BMI <30 kg/m2 but
not in subjects with BMI>30 kg/m2 [17]. Therefore the lower BMI of
this study population may have contributed to the inverse corre-
lation found. It has been proposed that the lack of association be-
tween CRP levels and n-3PUFA levels in obese participants is due to
increased levels of the n-6PUFA, arachidonic acid, in adipose tissue.
N-6PUFA are associated with the production of pro-inﬂammatory
cytokines [45]. Future studies assessing the association between
n-3PUFA and CRP within obese populations are warranted [46].
WBC are widely recognised as reliable biomarkers of inﬂam-
mation, however have not received the same attention as CRP with
respect to their relationship with n-3PUFA or their role in the
relationship between n-3PUFA levels and inﬂammation [47]. To our
knowledge, this is the ﬁrst study to explore the relationship be-
tween n-3PUFA levels and WBC and the WBC subgroups. Both O3I
and total n-3PUFA were inversely associated with WBC, monocyteand neutrophil cell counts independently, and with monocytes
when corrected for potential confounders. Total n-3PUFA was also
inversely related to WBC, neutrophils and monocytes following
multivariate adjustment for confounding variables. In addition, we
found inverse associations between DPA levels and WBC and
neutrophil counts. Since dietary intake is poorly correlated with
DPA levels, it is believed that DPA is predominately produced
endogenously from the elongation of EPA or retroconversion of
DHA [48]. Most observational studies have explored alterations in
WBC and WBC subgroup counts in relation to adherence to a
Mediterranean diet, and have shown a reduction inWBC, monocyte
and neutrophil count [49e51]. However this association cannot be
attributed to n-3PUFA levels alone as many other factors may
contribute to the health beneﬁts of a Mediterranean diet including
polyphenol, olive oil and legume intake [52,53]. Neutrophils and
monocytes are the ﬁrst WBC involved in the inﬂammatory
response. Our ﬁnding that higher levels of O3I and total n-3PUFA
are associated with reduced monocyte counts suggests that
increased intake of n-3PUFA may reduce the proliferation of in-
ﬂammatory WBC components [54].
This study did not detect an association between O3I and
ﬁbrinogen. Low ﬁbrinogen levels (3.5 g/L ± 0.6) within this study
population may be a likely reason for this lack of association. Par-
ticipants reported low levels of smoking and sedentary behaviour,
two factors that when elevated are associated with increasing
ﬁbrinogen levels, and had high HDL levels which is associated with
lower ﬁbrinogen levels [7,8]. Similarly Kalogeroulous et al. did not
ﬁnd an association between O3I and ﬁbrinogen in healthy Greek
male and female participants with ﬁbrinogen levels of 3.18 g/L and
3.14 g/L, respectively [13]. These ﬁndings support the postulate that
overall healthy lifestyle and dietary behaviours may have attenu-
ated the potential beneﬁts from higher n-3PUFA levels. Conversely,
in RCTs conducted in populations with elevated ﬁbrinogen levels,
supplementation has resulted in reductions in ﬁbrinogen levels of
10.6%e30.0% [55,56]. Similarly, an inverse association was found
between n-3PUFA levels and ﬁbrinogen in healthy cigarette
smoking males [57]. The results of the aforementioned studies
together with those of the current study suggest that the beneﬁts of
n-3PUFA in regards to reducing ﬁbrinogen levels may be most
pronounced in those with elevated ﬁbrinogen levels or in those
with lifestyle factors known to increase levels.
The current study had several strengths including the use of an
objective biomarker of long term dietary n-3PUFA intake rather
than dietary n-3PUFA intake alone. Dietary intake assessment is
known to have inherent measurement errors and bias [39]. The
relatively large sample and comprehensive data collection enabled
the identiﬁcation and analysis of potential confounding variables
such as smoking status, sedentary lifestyle, blood pressure, BMI,
fasting glucose levels, triglycerides and total cholesterol. Further-
more, as participants consuming n-3PUFA supplements were
excluded, ﬁndings were based on physiological erythrocyte con-
centrations; which provides a more objective measure of long term
PUFA exposure, taking into account intake and metabolism [18].
There are also some limitations, including the use of self-report
medical history and food frequency questionnaires which may be
subject to recall bias. In addition, although the study accounted for
many potential variables, we cannot exclude entirely that other
lifestyle or dietary patterns have not contributed to the afore-
mentioned associations. Finally, as this study was a cross-sectional
analysis, ﬁndings from this study cannot suggest causal inverse
relationships between n-3PUFA levels and inﬂammatory bio-
markers. Moreover, plasma samples were not available to measure
additional markers of inﬂammation such as IL-6 and TNFa, this
remains a weakness of the current study.
In conclusion we found a signiﬁcant independent inverse
M. Olliver et al. / Journal of Nutrition & Intermediary Metabolism 5 (2016) 61e6968association between erythrocyte n-3PUFA and circulating inﬂam-
matory biomarkers CRP, WBC, neutrophils and monocytes in a
cross-sectional analysis of older Australians. The inverse associa-
tion between O3I and monocytes, and between total n-3PUFA and
WBC, neutrophils and monocytes, persisted after multivariate ad-
justments for potential confounders. Future studies are required to
explore the potential anti-inﬂammatory effects of erythrocyte n-
3PUFA levels in other populations, including younger and over-
weight and obese adults.
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